Peter Barnes

Goldcorp, Inc. engages in the acquisition, exploration, development, operation, and reclamation gold and minerals. It operates through the following projects: Red Lake, Éléonore, Porcupine, Musselwhite, Peñasquito, Pueblo Viejo, Cerro Negro, Bajo de la Alumbrera, and others. The company was founded by Robert Ross McEwen on March 31, 1994 and is headquartered in Greenwood Village, CO.

Richmont Mines, Inc. engages in the exploration, operation, financing and development of mineral properties. The company was founded on February 12, 1981 and is headquartered in Rouyn-Noranda, Canada.

Wheaton River Minerals Ltd., subsidary of Gold Corp., Inc. It is a producer of gold and precious metals with significant assets and operations in Mexico, Australia and Argentina. Based in Vancouver, British Columbia.

Alloycorp Mining, Inc. engaged in the acquisition, exploration, and development of mineral properties in Canada. The firm explored for molybdenum deposits. It holds interest in Avanti Kitsault project. The company was founded on February 2, 2006 and was headquartered in Toronto, Canada.

The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016.

The Silver Institute operates as a non-profit international association. The firm offers leading silver mining houses, refiners, bullion suppliers, manufacturers of silver products and wholesalers of silver investment products. The company was founded in 1971 and is headquartered in Washington, DC.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.